Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 6OSELTAMIVIR PHOSPHATE
02 1RIZATRIPTAN BENZOATE
03 2TAMIFLU
01 121087
02 121246
03 1203478
04 1208347
05 1209113
06 1210186
07 1211125
08 1211894
09 1212858
01 9No
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : OSELTAMIVIR PHOSPHATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 211894
Country : US
Patented : No
Drug : OSELTAMIVIR PHOSPHATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 210186
Country : US
Patented : No
Drug : TAMIFLU
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 21246
Country : US
Patented : No
Drug : OSELTAMIVIR PHOSPHATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 212858
Country : US
Patented : No
Drug : OSELTAMIVIR PHOSPHATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 208347
Country : US
Patented : No
Drug : RIZATRIPTAN BENZOATE
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 203478
Country : US
Patented : No
Drug : OSELTAMIVIR PHOSPHATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 211125
Country : US
Patented : No
Drug : OSELTAMIVIR PHOSPHATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 209113
Country : US
Patented : No
